We have observed
4 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 14, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
HIGH DRUG LOAD TABLET FORMULATION OF BRIVANIB ALANINATE
USE OF STRIGOLACTONES AND STRIGOLACTONE ANALOGS FOR TREATING PROLIFERATIVE CONDITIONS
METHOD FOR PREPARING 1,2,3-TRIMETHOXYPROPANE, USES THEREOF, AND COMPOSITIONS INCLUDING SAID 1,2,3-TRIMETHOXYPROPANE
PROCESS FOR PREPARING A POLYOL ETHER